Sirtex Medical’s SIR-Spheres Y-90 Resin Microspheres Receive FDA Approval for the Treatment of Unresectable Hepatocellular Carcinoma
Expanded indication makes SIR-Spheres® the first and only radioembolization therapy in the…
GameChange Solar Secures Landmark 1.25 GW Tracker Deal for Abydos II in Egypt
DUBAI, UAE, July 7, 2025 /PRNewswire/ -- GameChange Solar, a leading global…
Fictiv Receives Frost & Sullivan’s 2025 Global Supply Chain for Custom Mechanicals Technology Innovation Leadership Recognition
Recognized for its innovative approach to global supply chain orchestration, delivering customer…
UroGen Announces Completion of Enrollment in the Phase 3 UTOPIA Clinical Trial of UGN-103 for the Treatment of Recurrent Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer
PRINCETON, N.J., July 07, 2025 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq:…
LENZ Therapeutics and Laboratoires Tha Announce Exclusive License and Commercialization Agreement for LNZ100 in Canada
Exclusive agreement includes over $70 million in upfront and milestone payments to…
KALA BIO to Host Virtual Key Opinion Leader (KOL) Event to Discuss the Potential of KPI-012 for the Treatment of Persistent Corneal Epithelial Defect (PCED)
July 07, 2025 08:00 ET | Source: KALA BIO, Inc. ARLINGTON, Mass.,…
Ripple is applying for a national bank charter, LET Mining creates more value for XRP holders
New York City, NY, July 06, 2025 (GLOBE NEWSWIRE) -- Ripple (XRP)…
AB Science: Masitinib receives FDA and EMA authorization for confirmatory phase 3 trial in metastatic castrate-resistant prostate cancer
PRESS RELEASE MASITINIB RECEIVES FDA AND EMA AUTHORIZATION FOR CONFIRMATORY PHASE 3…
Orion publishes Half-Year Financial Report for JanuaryJune 2025 and holds a webcast on 18 July 2025
July 04, 2025 02:00 ET | Source: Orion Oyj ORION CORPORATION PRESS…
13th World Peace Forum held in Beijing, calls for shared responsibility in global peace
BEIJING, July 5, 2025 /PRNewswire/ -- Diplomats, scholars, and policymakers from more…
